European Commission Clears Four NMEs Ahead Of FDA In 1998
Executive Summary
Four of the 17 new molecular entities approved by the European Commission in 1998 have not yet cleared FDA.
You may also be interested in...
EMEA Clears Four Biologics In 1999 Before FDA, And Five Later Than FDA
The European Medicines Evaluation Agency approved four biological products in 1999 that have not yet been licensed by FDA.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011